Marc P GIRARD, 49 rue d'Aubigny, 69003, LYON,France Cell: +33 (0) 680 237 682 E-mail: email@example.com Marc Girard received his doctorate in veterinary medicine at Paris University in 1960, and his doctorate in Science in 1967, also in Paris. He trained in the molecular biology of poliovirus as a Post-doctoral Fellow in the USA and France. He then studied the molecular biology and genetics of poliovirus, SV40, and adenovirus, before moving to HIV. He worked for the last 20 years of his career on the development of an HIV vaccine. Pr Girard was the Director General of the Mérieux Foundation in Lyon from 2001 to end of 2003 He previously was the Director of the Center for Research in Immuno-Virology (CERVI) in Lyon, which includes the French BSL4 Laboratory . Among the positions held by Dr Girard prior to his appointment in Lyon were Chief, Department of Virology, and Professor, Institut Pasteur, Paris (1980-1999); Scientific Director, Pasteur Vaccins, a joint industrial subsidiary of the Pasteur and Mérieux Institutes (1984-1989); and Professor of Virology and Molecular Biology at University Paris 7 Denis Diderot, Paris (since 1974). Pr Girard was in charge of the Concerted Action “Vaccines” at the French National AIDS Research Agency (ANRS) from 1988 to 1998. He chaired the E.U. HIV Vaccine Initiative “EuroVac”, an international AIDS vaccine Research Consortium which grouped together 21 European laboratories participating in comparative Phase I clinical trials of candidate HIV vaccines in human volunteers. Marc Girard went on official retirement on January 2004 but has remained active as a consultant with WHO and with several biotech companies. He still teaches, gives talks and writes papers as an Honorary Professor at University Denis Diderot-Paris 7. He also is a member of the French National Academy of Medicine.
Biography Updated on 27 October 2011